Month: May 2023
-
Crispr Therapy Shown to Reduce Harmful Gut Microbes
A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects.
-
Precision T-Cell Solid Tumor Therapy Trial Underway
A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells.
-
Memorial Day, 2023
We’ll resume our editorial posting tomorrow.
-
Infographic – More US Support for Childhood Vaccines Than Covid-19
A recent poll shows U.S. adults continue to favor vaccinations against the childhood diseases mumps, measles, and rubella, but show less support for Covid-19 vaccines.
-
AI-Designed Cancer Vaccine Shown to Act Against Melanoma
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors.
-
Low-Dose Oral Film Reduces Mental Disorder Agitation
Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia.
-
Pharma Company Gains Precise Gene Edits in $2B Biotech Deal
A global drug maker is acquiring access to a biotechnology company’s precise genome editing techniques to develop new therapies for rare and cardiometabolic disorders.
-
Lab to Develop New Bio-Based Sustainable Materials
A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis.
-
Safer Forms of Psilocybin Assessed in Preclinical Study
A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects.
-
Infographic – U-Turn on A.I. Venture Funds in Q1
Both the total investment dollars and number of venture deals in Q1 2023 are the lowest single quarter totals since 2019.